Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | -3.19% | -4.71% | -45.35% |
Financials (USD)
Sales 2024 * | 261M | Sales 2025 * | 358M | Capitalization | 209M |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | -27M | EV / Sales 2024 * | 1.83 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.38 x |
P/E ratio 2024 * |
5.64
x | P/E ratio 2025 * |
-8
x | Employees | 249 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.96% |
Latest transcript on Coherus BioSciences, Inc.
1 day | -3.19% | ||
1 week | -4.71% | ||
1 month | -7.14% | ||
3 months | -20.18% | ||
6 months | -14.55% | ||
Current year | -45.35% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.82 | -3.19% | 967,092 |
24-05-30 | 1.88 | +2.17% | 1,749,408 |
24-05-29 | 1.84 | -2.13% | 1,585,371 |
24-05-28 | 1.88 | -1.57% | 1,173,615 |
24-05-24 | 1.91 | -4.98% | 1,444,636 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.35% | 209M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CHRS Stock